Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
201
-
Total 13F shares, excl. options
-
50.4M
-
Shares change
-
+893K
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$16M
-
Put/Call ratio
-
3.04
-
Number of buys
-
98
-
Number of sells
-
-97
-
Price
-
$20.84
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2020
238 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2020.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 50.4M shares
of 56M outstanding shares and own 90.08% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.08M shares), VANGUARD GROUP INC (5.21M shares), ARMISTICE CAPITAL, LLC (3.2M shares), MACQUARIE GROUP LTD (2.05M shares), DIMENSIONAL FUND ADVISORS LP (1.96M shares), RENAISSANCE TECHNOLOGIES LLC (1.87M shares), STATE STREET CORP (1.77M shares), Aristotle Capital Boston, LLC (1.07M shares), GW&K Investment Management, LLC (1.05M shares), and RICE HALL JAMES & ASSOCIATES, LLC (1.01M shares).
This table shows the top 201 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.